Abstract
Background: The incidence of oral tongue squamous cell carcinoma (OTSCC) is increasing among younger birth cohorts. The etiology of early-onset OTSCC (diagnosed before the age of 50 years) and cancer driver genes remain largely unknown. Methods: The Sequencing Consortium of Oral Tongue Cancer was established through the pooling of somatic mutation data of oral tongue cancer specimens (n = 227 [107 early-onset cases]) from 7 studies and The Cancer Genome Atlas. Somatic mutations at microsatellite loci and Catalog of Somatic Mutations in Cancer mutation signatures were identified. Cancer driver genes were identified with the MutSigCV and WITER algorithms. Mutation comparisons between early- and typical-onset OTSCC were evaluated via linear regression with adjustments for patient-related factors. Results: Two novel driver genes (ATXN1 and CDC42EP1) and 5 previously reported driver genes (TP53, CDKN2A, CASP8, NOTCH1, and FAT1) were identified. Six recurrent mutations were identified, with 4 occurring in TP53. Early-onset OTSCC had significantly fewer nonsilent mutations even after adjustments for tobacco use. No associations of microsatellite locus mutations and mutation signatures with the age of OTSCC onset were observed. Conclusions: This international, multicenter consortium is the largest study to characterize the somatic mutational landscape of OTSCC and the first to suggest differences by age of onset. This study validates multiple previously identified OTSCC driver genes and proposes 2 novel cancer driver genes. In analyses by age, early-onset OTSCC had a significantly smaller somatic mutational burden that was not explained by differences in tobacco use. Lay Summary: This study identifies 7 specific areas in the human genetic code that could be responsible for promoting the development of tongue cancer. Tongue cancer in young patients (under the age of 50 years) has fewer overall changes to the genetic code in comparison with tongue cancer in older patients, but the authors do not think that this is due to differences in smoking rates between the 2 groups. The cause of increasing cases of tongue cancer in young patients remains unclear.
Original language | English |
---|---|
Pages (from-to) | 544-553 |
Number of pages | 10 |
Journal | Cancer |
Volume | 127 |
Issue number | 4 |
DOIs | |
State | Published - Feb 15 2021 |
Bibliographical note
Publisher Copyright:© 2020 American Cancer Society
Funding
Ryan J. Li reports personal fees and other from Intuitive Surgical outside the submitted work. Glenn J. Hanna reports grants from Bristol‐Myers Squibb, GlaxoSmithKline, NantKwest/Altor Bioscience, Kite, Kartos, Elevar, the ASCO Conquer Cancer Foundation, the V Foundation, and Gateway for Cancer Research; grants and personal fees from Exicure, Regeneron, Sanofi Genzyme, and Bicara; and personal fees from Bio‐Rad, Kura, Maverick, Prelude, and Merck outside the submitted work. The other authors made no disclosures. This work was supported by the National Cancer Institute (K07CA218247; principal investigator Krystle A. Lang Kuhs). Curtis R. Pickering reports grants from the National Institute of Dental and Craniofacial Research during the conduct of the study. The University of Texas MD Anderson Cancer Center is supported by the National Institutes of Health (grant P30 CA016672).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | P30 CA016672 |
National Institutes of Health (NIH) | |
National Childhood Cancer Registry – National Cancer Institute | K07CA218247 |
National Childhood Cancer Registry – National Cancer Institute | |
National Institute of Dental and Craniofacial Research | |
Conquer Cancer Foundation | |
Gateway for Cancer Research | |
GlaxoSmithKline |
Keywords
- NOTCH1
- TP53
- age of onset
- oral tongue cancer
- tobacco
ASJC Scopus subject areas
- Oncology
- Cancer Research